Category Archives: Uncategorized
Brand Lifecycle Management: Strategies for Every Budget
At every investment level, superior strategies emerge Many pharmaceutical companies use strategies to extend the commercial life of mature pharmaceutical brands and minimize market share decline, but Best Practices LLC and RxSolutions have identified superior strategies across different investment levels
Best Practices Hosting 6th Medical Affairs Consortium on HEOR
Best Practices will be hosting the sixth roundtable of our Medical Affairs Consortium on Thursday (May 28th) from 11:00AM-12:30PM (EST) via a virtual roundtable to discuss “Medical Affairs’ Role in Health Economics & Outcomes Research.” This is the final roundtable
As Mobile Surpasses Desktop Search, Poll of Digital Marketers Finds Industry Divided on Pharma’s Next Steps
In a digital advertising conference yesterday, Google announced that mobile searches have surpassed desktop searches in the U.S. and numerous other countries. This is big news, but a not necessarily stunning development to anyone paying close attention to the inexorable
One Way to Please the Boss (& the Boss’s Boss): Crafting Highly Effective Executive Briefs
A quick peek behind the curtain at the Best Practices Research Center and a Most Interesting Case that recently landed on my desk. We are a consulting firm whose clients work mainly in the pharma and biotech sector. As a
Exclusive: Key Findings from Best Practices’ 5th Medical Affairs Consortium
Best Practices recently completed the second roundtable of our 2014-2015 Medical Affairs Consortium. The roundtable addressed the topic of “Medical Affairs Launch Support.” The roundtable brought together executives from 13 leading pharmaceutical organizations. Some exclusive key findings from the discussion
Patient Centricity Has Arrived. Bigger Question: Where Is It Headed?
Patients have always been on pharma’s radar, though it has historically been as a target of marketing (the most obvious being Direct to Consumer (DTC) advertising). But now under the banner of Patient Centricity, pharma companies large and small are
Top Trends in 2015 – Is Your Organization Prepared?
2015 is here & with the New Year comes many new trends and topics of discussion. With the increasing importance of payers and high demand on evidence-based information, it is clear that there are many shifts happening in the pharmaceutical,
Internal Communication Commandments to Live By
In order to improve an organization as a whole, it is critical to improve internal corporate communications. Best Practices, LLC’s work highlights how companies deliver their internal messages and find the proper balance between informing and educating employees. We have seen companies
Best Practices in Lifecycle Management: Maximizing the Potential of Mature Brands
As many drugs are reaching the patent cliff, strategies to extend the commercial life of mature brands is critical to today’s pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as 10 years and billions of dollars to
Medical Affairs Consortium: Impact Measures, Globalization & Compliance
On November 6, 2014 Best Practices, LLC hosted the 1st roundtable of the 2014-2015 Medical Affairs’ Consortium. The roundtable brought together leaders from: Baxter, Crescendo, Eli Lilly, Genentech, Incyte Corporation, Jazz Pharmaceuticals, Pfizer, Santen Inc., Teva, and Upsher-Smith. Leaders from
How To: Stop “No” From Being a 4-Letter Word
Not too long ago, a colleague jokingly compared me to a consigliere. (Think Marlon Brando in “The Godfather”). He said he didn’t know how I got any work done, as people wander in and out of my office to speak
5 Things Pharma Professionals Need to Know About Big Data
Big Data has its roots in a set of statistical methods called econometrics A main feature of the finance, biology, and the social sciences is the apparent randomness of the behaviors being measured. Econometrics exists to distill the random and